CN107137677A - Warm sun patch - Google Patents
Warm sun patch Download PDFInfo
- Publication number
- CN107137677A CN107137677A CN201710216722.4A CN201710216722A CN107137677A CN 107137677 A CN107137677 A CN 107137677A CN 201710216722 A CN201710216722 A CN 201710216722A CN 107137677 A CN107137677 A CN 107137677A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- medicine composition
- radix
- osteoarthropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims abstract description 37
- 206010057178 Osteoarthropathies Diseases 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 17
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 17
- 241000427159 Achyranthes Species 0.000 claims abstract description 16
- 241000212321 Levisticum Species 0.000 claims abstract description 16
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 16
- 235000005412 red sage Nutrition 0.000 claims abstract description 16
- 241000758794 Asarum Species 0.000 claims abstract description 15
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 15
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 15
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 15
- 240000004980 Rheum officinale Species 0.000 claims abstract description 15
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 15
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 14
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 14
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 13
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 13
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 13
- 241000951473 Schizonepeta Species 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 12
- 240000007594 Oryza sativa Species 0.000 claims abstract description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 12
- 239000011505 plaster Substances 0.000 claims abstract description 12
- 235000009566 rice Nutrition 0.000 claims abstract description 12
- 235000021419 vinegar Nutrition 0.000 claims abstract description 12
- 239000000052 vinegar Substances 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 6
- 229920003023 plastic Polymers 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 60
- 239000002994 raw material Substances 0.000 claims description 11
- 244000056139 Brassica cretica Species 0.000 claims description 2
- 235000003351 Brassica cretica Nutrition 0.000 claims description 2
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 2
- 235000001667 Vitex agnus castus Nutrition 0.000 claims description 2
- 244000063464 Vitex agnus-castus Species 0.000 claims description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 2
- 235000010460 mustard Nutrition 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 6
- 206010034464 Periarthritis Diseases 0.000 abstract description 5
- 201000003068 rheumatic fever Diseases 0.000 abstract description 5
- 201000005671 spondyloarthropathy Diseases 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 description 23
- 238000000034 method Methods 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 201000008482 osteoarthritis Diseases 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 241000545442 Radix Species 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010005963 Bone formation increased Diseases 0.000 description 2
- 241001269238 Data Species 0.000 description 2
- 206010017577 Gait disturbance Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000005065 subchondral bone plate Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008334 Cervicobrachial syndrome Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010065564 Floating patella Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000002089 crippling effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 201000010930 hyperostosis Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of entitled temperature sun patch of the present invention, and in particular to Chinese medicine composition and its preparation and preparation method for treating osteoarthropathy.It is an object of the invention to provide a kind of Chinese medicine composition for treating osteoarthropathy, it can treat osteoarthropathy, have preferable therapeutic effect to osteoproliferation, scapulohumeral periarthritis, rheumatic arthritis, rheumatoid arthritis, cervical spondylopathy etc..Including following medicine composition：Radix Angelicae Sinensis, the red sage root, frankincense, myrrh, the root of bidentate achyranthes, levisticum, cassia twig, asarum is windproof, schizonepeta, the Radix Astragali, rhizoma zingiberis, rhizoma cibotii, tag processed, the coptis, radix scutellariae, rheum officinale.Another aspect of the present invention provides a kind of preparation method of external use plaster, specifically includes following steps：Dry medicine materical crude slice is taken, fine powder is worn into pulverizer, 120 mesh sieves is crossed, is put into container.Add rice vinegar, be tuned into dough, by 6g Chinese medicine dough hand rubbings into wad, be put on gauze, cover layer of transparent plastic paper, with finger press into diameter 8cm circular shaped plaster.
Description
Technical field
The present invention relates to key areas, and in particular to it is a kind of treat Bones and joints and Chinese medicine composition and its preparation and preparation
Method.
Background technology
Osteoarthropathy（osteoarthritis, OA）Mainly based on cartilage, ligament, subchondral bone matter and synovial membrane inflammation
Lesion is wanted, the progressive degenerative disease of total joint structure is then influenceed.Osteoarthropathy has substantial connection with age and wound,
Therefore also known as degenerative arthritis.It is one of influence most common disease of human health, and is easier to influence compared with other diseases
The capacity of gerontal patient, is to cause more than 50 years old crowd's function to be damaged, causes the master of economic loss and influence social development
Want one of disease.
At present, the treatment for these diseases has Chinese traditional treatment method, also there is western medical treatment method, and Chinese traditional treatment is usually
Using treatment method promoting blood circulation and removing blood stasis, but the purpose of recovery from illness is unable to reach using this method.With western medical treatment, generally using hand
Art is treated, although operative treatment can play certain curative effect, is performed the operation and is brought great pain to the body and mind of patient.
The content of the invention
It is an object of the invention to provide a kind of Chinese medicine composition for treating osteoarthropathy, it can treat osteoarthropathy,
There is preferable therapeutic effect to cervical spondylopathy, osteoproliferation, scapulohumeral periarthritis, rheumatic arthritis, rheumatoid arthritis etc..The present invention
The preparation and preparation method of a kind of above-mentioned composition are additionally provided simultaneously.
The technical solution adopted in the present invention is：
A kind of external medicine composition for treating osteoarthropathy, it includes following medicine composition：
Radix Angelicae Sinensis, the red sage root, frankincense, myrrh, the root of bidentate achyranthes, levisticum, cassia twig, asarum is windproof, schizonepeta, the Radix Astragali, rhizoma zingiberis, rhizoma cibotii, tag processed,
The coptis, radix scutellariae, rheum officinale.
It is preferred that, the external medicine composition of above-mentioned treatment osteoarthropathy, it include following weight than raw material：
10-30 parts of Radix Angelicae Sinensis, 15-45 parts of the red sage root, 6-18 parts of frankincense, 6-18 parts of myrrh, 8-28 parts of the root of bidentate achyranthes, 8-28 parts of levisticum, cassia twig
5-25 parts, 3-15 parts of asarum is windproof 6-30 parts, 6-18 parts of schizonepeta, 10-30 parts of the Radix Astragali, 5-25 parts of rhizoma zingiberis, 10-40 parts of rhizoma cibotii, system
6-18 parts of tag, 3-9 parts of the coptis, 3-15 parts of radix scutellariae, 2-8 parts of rheum officinale.
It is preferred that, the external medicine composition of above-mentioned treatment osteoarthropathy, it include following weight than raw material：
15-25 parts of Radix Angelicae Sinensis, 25-35 parts of the red sage root, 10-14 parts of frankincense, 10-14 parts of myrrh, 15-21 parts of the root of bidentate achyranthes, 15-21 parts of levisticum,
10-20 parts of cassia twig, 6-12 parts of asarum is windproof 12-24 parts, 9-15 parts of schizonepeta, 15-25 parts of the Radix Astragali, 10-20 parts of rhizoma zingiberis, rhizoma cibotii 20-
30 parts, tag 9-15 parts processed, 5-7 parts of the coptis, 6-12 parts of radix scutellariae, 4-6 parts of rheum officinale.
Most preferably, the external medicine composition of above-mentioned treatment osteoarthropathy, it include following weight than raw material：
The windproof 18 portions of chaste trees of 20 parts of Radix Angelicae Sinensis, 30 parts of the red sage root, 12 parts of frankincense, 12 parts of myrrh, 18 parts of the root of bidentate achyranthes, 18 parts of levisticum, 15 parts of cassia twig, 9 portions of asarum
12 parts of mustard, 20 parts of the Radix Astragali, 15 parts of rhizoma zingiberis, 25 parts of rhizoma cibotii, 12 portions of tag, 6 parts of the coptis, 9 parts of radix scutellariae, 5 parts of rheum officinale processed
Another aspect of the present invention provides a kind of preparation method of external use plaster, specifically includes following steps：Dry medicine materical crude slice is taken, is used
Pulverizer wears into fine powder, crosses 120 mesh sieves, is put into container.Rice vinegar is added, dough is tuned into.Then hospital gauze is cut into 10*
10cm square, by 6g Chinese medicine dough hand rubbings into wad, is put on gauze, covers layer of transparent plastic paper, slow with finger
The slow circular shaped plaster that diameter 8cm is forced into surrounding.
Further, it is characterised in that by traditional Chinese medicine fine powder and rice vinegar 1：1 weight is than adding rice vinegar.
In the present invention：
Radix Angelicae Sinensis-enriching blood purifies the blood, deficiency of blood blood is turbid, the weak numbness pain of impotence, and blood-breaking life is new.
The red sage root-promoting blood circulation for regulating menstruation, trusted subordinate's perverse trend, fever and chills accumulation, place blood lochia.
Muscle is stretched in frankincense-promoting blood circulation, by degrading the channel, expelling wind and clearing away cold, analgesic therapy of invigorating blood circulation.
Myrrh-dissipate blood detumescence, analgesic therapy myogenic, blood-breaking analgesic is torn open and hinders extravasated blood.
The root of bidentate achyranthes-cold-dampness Impotence numbness, spasm of limbs, arthralgia tonifies the liver and kidney.
Levisticum-wind pain is had a headache, and bodily pain pin pain, articular instability, rheumatism blocks up numbness.
Cassia twig-warming meridians and promoting circulation of qi, cheiropodagra, harmonizing yingfen and weifen, horizontal logical podomere.
Asarum-cough inverse headache, joint contraction, arthralgia pain due to rheumatism, improving eyesight is sensible.
It is windproof-to dissipate table sweating, wind bodily pain is blocked up, liver purging the liver of pathogenic fire is searched, wind prevailing over dampness is dissipated.
Schizonepeta-general mood harmony expires, crest pain, the tired pain of muscles and bones, brothers' muscular contracture.
The Radix Astragali-replenishing and restoring lung qi, the deficient exhaustion or lesion of the five internal organs, variola ulcer, eliminating toxic analgesic.
Rhizoma zingiberis-and except cold dissipating bind, middle benefit gas is by cold, Back to Yang Tongmai, cold limbs.
Rhizoma cibotii-tonifying Qi and blood, strengthening tendons benefit bone, caused by liver and kidney deficiency, the weak pain in the back of waist.
Tag processed-help positive Hui Yuan, mends fire and moves back cold, cold-dampness crippling wilt, deficiency-cold in spleen and stomach.
The coptis-thermal burn channels, blood overflows skin, then is hair spot, three burnt accumulated heats.
The inverse lung key of radix scutellariae-heat, then be hematemesis, clearing damp heat-clearing, and it imitates quite prompt.
Rheum officinale-hot harmony skin, then be carbuncle swells, expel the heat-evil by the stasis of blood, weed out the old and bring forth the new.
The present invention is directed to the clinical characters of osteoarthropathy, has prepared Radix Angelicae Sinensis, the red sage root, frankincense, myrrh, the root of bidentate achyranthes with promoting blood circulation
The stasis of blood, swelling and pain relieving.Levisticum, cassia twig, asarum, windproof, schizonepeta, the Radix Astragali are with inducing diaphoresis to dispel wind, warming meridian.Rhizoma zingiberis, rhizoma cibotii, tag processed
With the beneficial bone of strengthening tendons, warming and invigorating kidney Yang.The coptis, radix scutellariae, rheum officinale by the stasis of blood to expel the heat-evil.Collective effect can be subtracted with the work(of concurrence blood-activating analgetic
The clinical symptoms of light osteoarthropathy, can be treated with help kidney yang from the basic origin cause of formation of disease.To cervical spondylopathy, hyperostosis
Life, scapulohumeral periarthritis, rheumatic arthritis, rheumatoid arthritis etc. have preferable therapeutic effect.
Embodiment
The present invention is illustrated in further detail below in conjunction with embodiment.
Embodiment 1
It is a kind of adjust osteoarthropathy Chinese medicine composition, by following weight than raw material：20 parts of Radix Angelicae Sinensis, 30 parts of the red sage root, 12 parts of frankincense
Windproof 12 parts of 18 portions of schizonepeta, 20 parts of the Radix Astragali, the 15 parts of rhizoma cibotii 25 of rhizoma zingiberis of 12 parts of myrrh, 18 parts of the root of bidentate achyranthes, 18 parts of levisticum, 15 parts of cassia twig, 9 parts of asarum
Part 12 portions of tag, 6 parts of the coptis, 9 parts of radix scutellariae, 5 parts of rheum officinale processed.
Dry medicine materical crude slice is taken, fine powder is worn into pulverizer, 120 mesh sieves is crossed, is put into container.Rice vinegar is added, dough is tuned into.
Then hospital gauze is cut into 10*10cm square, by 6g Chinese medicine dough hand rubbings into wad, is put on gauze, covers one
Layer transparent plastic paper, diameter 8cm circular shaped plaster is slowly forced into finger to surrounding.
Embodiment 2
It is a kind of adjust osteoarthropathy Chinese medicine composition, by following weight than raw material：Radix Angelicae Sinensis 20g red sage root 30g frankincense 12g myrrhs
The windproof 18g schizonepeta 12g Radixs Astragali 20g rhizoma zingiberis 15g rhizoma cibotii 25g tags 12g of 12g root of bidentate achyranthes 18g levisticum 18g cassia twig 15g asarums 9g are yellow
Connect 6g radix scutellariae 9g rheum officinales 5g.Preparation method be the same as Example 1.
Embodiment 3
It is a kind of adjust osteoarthropathy Chinese medicine composition, by following weight than raw material：Radix Angelicae Sinensis 15g red sage root 20g frankincenses 9g does not have
The windproof 12g schizonepeta 10g Radixs Astragali 15g rhizoma zingiberis 12g rhizoma cibotii 20g systems of medicine 9g root of bidentate achyranthes 12g levisticum 12g cassia twig 10g asarums 6g
Tag 10g coptis 4g radix scutellariae 6g rheum officinales 3g.Preparation method be the same as Example 1.
Embodiment 4
It is a kind of adjust osteoarthropathy Chinese medicine composition, by following weight than raw material：Radix Angelicae Sinensis 40g red sage root 60g frankincenses 24g
The windproof 36g schizonepeta 24g Radixs Astragali 40g rhizoma zingiberis 30g rhizoma cibotii of myrrh 24g root of bidentate achyranthes 36g levisticum 36g cassia twig 30g asarums 18g
50g tag 24g coptis 12g radix scutellariae 18g rheum officinales 10g.Preparation method be the same as Example 1.
Embodiment 5
It is a kind of adjust osteoarthropathy Chinese medicine composition, by following weight than raw material：Radix Angelicae Sinensis 10g red sage root 15g frankincenses 6g does not have
The windproof 9g schizonepeta 9g Radixs Astragali 10g rhizoma zingiberis 7.5g rhizoma cibotii 12g systems of medicine 6g root of bidentate achyranthes 9g levisticum 9g cassia twig 7.5g asarums 4.5g
Tag 6g coptis 3g radix scutellariae 4.5g rheum officinales 2.5g.Preparation method be the same as Example 1.
Above-described is only some embodiments of the present invention.For the person of ordinary skill of the art, not
On the premise of departing from the invention design, various modifications and improvements can be made, these belong to the protection model of the present invention
Enclose.
Embodiment 6
1 data and method
1.1 clinical datas and group technology
Selected case is from October, 2015 to the medical Human Osteoarthritis in Tian Run in June, 2016 hospitals of traditional Chinese hospital, Chinese medical discrimination
Parting belongs to cold-dampness syndrome.Using random, parallel control Clinical Study Protocol, with district's groups method of randomization, SAS softwares are utilized
Selected patient is randomly divided into 2 groups by PROCPLAN sentences：Treatment group and control group.Symptom before two groups of patient's general information and treatment
Sign situation is shown in Table 1, and it is not statistically significant to compare difference between the sex ratio of two groups of patients, average age, course of disease group（P>
0.05）, with comparativity.
1 two groups of general clinical datas of patient of table compare（±s）
| Group | Number of cases | Man | Female | Age（Year） | The course of disease（My god） |
| Treatment group | 20 | 12 | 8 | 51.3±11.3 | 43.2±61.0 |
| Control group | 20 | 11 | 9 | 50.9±13.7 | 40.7±54.1 |
1.2 diagnostic criteria
Domestic orthopaedics and rheumatism are immunized section expert and have drafted osteoarthritis diagnosis and treatment guide under the support of the Ministry of Public Health within 2007.Knee
Joint osteoarthritis diagnostic criteria：1. gonalgia repeatedly in nearly 1 month；2. X-ray film（Stand or Weight carrying position）Show between joint
Gap narrows, Subchondral bone sclerosis and（Or）Cystis degeneration, joint margins spur are formed；3. joint fluid（At least 2 times）It is limpid, sticky, WBC
< 2000 mL-1；4. middle-older patient（>=40 years old）；5. morning stiffness≤30min；6. there is bony crepitus when movable（Sense）.Wherein meet
1+ 2 or 1+ 3+ 5+ 6 or 1+ 4+ 5+ 6, diagnosable knee joint osteoarthritis.
1.3 inclusive criteria
1. knee osteoarthritis diagnosis is met；
2. Chinese medical discrimination is demonstrate,proved for cold-dampness numbness；
3. the age is between 40-70 Sui；
4. gonalgia visual analogue scales（Visual Analogue Scale,VAS）Scoring >=2；
5. informed consent form is voluntarily signed.
1.4 exclusion standard
1. the diseases such as serious cardiovascular, lung, liver, kidney, hemopoietic system are associated with；
2. the disease itself showed with arthritis, such as rheumatoid arthritis, ankylosing spondylitis, gout（Stage of attack）；
3. the disease in joint is had influence on complication, such as psoriasis, luetic neuropathy, ochronosus, metabolic bone disease, acute
Wound etc.；
4. it is inscribed within 4 weeks and has received glucocorticoid treatment（But receive glucocorticoid treatment dose stability at least 4 weeks；And recidivist
Except）；
5. nonsteroidal anti inflammatory anodyne was used to treat in 2 weeks（But it is steady to receive nonsteroidal anti inflammatory anodyne therapeutic dose
Determine at least 2 weeks and except hair author）；
6. pregnant woman or women breast-feeding their children or mental patient；
7. there are external plaster allergies；
8. other drugs clinical test is being participated in；
9. researcher thinks have other reasonses to be not suitable for clinical test.
1.5 treatment method
1.5.1 the phase is eluted
1. the elution phase for taking or using non-steroidal anti-inflammatory painkiller thing person to pass through 2 weeks；
2. the patient for receiving hormone therapy have to be larger than 30d into experiment predose is stable, and treatment is entered after the elution phase.
1.5.2 treatment group's administrated method
The attached temperature sun patch in osmanthus is main to be made up of cassia twig, monkshood, the root of bidentate achyranthes, the positive eliminating toxic dampness and heat medicine of levisticum isothermal.By the Tian Run hospitals of traditional Chinese hospital
Pharmacy is ground Chinese herbal medicine with medicinal herb grinder respectively, is sieved with 120 mesh sieves, and mixing is admixed in proportion and is formed, is passed through
Various techniques, hybrid modulation paste making agent external application.Each 20g, once a day, the course for the treatment of 4 weeks.
1.5.3 control group administrated method
By Diclofenac（Novartis Pharma AG produces, authentication code:Chinese medicines quasi-word H19990291）Extrude every time
About 10cm or so, uniform outer be applied to suffers from knee, and gently rubs to medicine completely into tissue, and 3 times a day, continuous 2 weeks.
1.6 observation index and quantization modulation
Grade form is formulated with reference to Lequesne knee osteoarthritis seriousness and activity index Evaluation Method（Table 2）, respectively at treatment
Before, treatment after 2 weeks, treatment after 1 month to patient progress clinical score.
The knee osteoarthritis clinical score table of table 2
| Project | Scoring | Project | Scoring |
| Pain or discomfort | 3. squat down | ||
| 1. during night's rest | Normally | 0 | |
| Nothing is slight | 0 | It can complete, but sense is difficult | 1 |
| Only in motion or certain posture | 1 | Can not | 2 |
| When motionless | 2 | 4. walked on uneven road | |
| 2. the morning stiffness time after getting up（min） | Normally | 0 | |
| <1 | 0 | It can stand | 1 |
| 1-15 | 1 | Cannot | 2 |
| >15 | 2 | Sign | |
| 3. during walking | 1. tenderness | 0 | |
| Without discomfort | 0 | Normally | 0 |
| Only after a segment distance of walking | 1 | Pain during weight | 1 |
| Start uncomfortable after walking aggravate | 2 | Pain during moderate pressure | 2 |
| 4. maximum walking distance（m） | Light pressure is pain | ||
| Unrestrictedly | 0 | 2. kneecap mobility（cm） | |
| >1000 | 1 | >2.0 | 0 |
| 1000 | 2 | 2.0-1.0 | 1 |
| <1000-900 | 3 | <1.0-0.5 | 2 |
| <900-500 | 4 | <0.5-0.2 | 3 |
| <500-100 | 5 | 3. range of motion（） | |
| <100 | 6 | >120 | 0 |
| Daily routines | 120-110 | 1 | |
| 1. go upstairs | <110-90 | 2 | |
| Without influence | 0 | <90-60 | 3 |
| Pain but reluctantly can on | 1 | <60-20 | 4 |
| It can not go up or highly difficult | 2 | 4. swelling | |
| 2. go downstairs | Nothing | 0 | |
| Without influence | 0 | Slightly swell, Xiyan understands | 1 |
| Pain but reluctantly can on | 1 | Xiyan is not clear | 2 |
| It can not go up or highly difficult | 2 | Xiyan is unclear, floating patella phenomenon（+） | 3 |
Knee osteoarthritis VAS scores, using visual analogue scales（Visual Analogue Scale, VAS）：Use a length
100mm pain visual imitation assessment scale, each scale represents 1 point, 100 points of total score.0mm ends represent painless, i.e., 0 point,
100mm ends represent insufferable most violent pain, i.e., 100 points, by graduated one side dorsad patient during Clinical practice, allow
Patient marks on scale can represent the position of oneself pain degree, scale corresponding to the position that marks of doctor record patient and
Fraction.Before treatment, after treatment scoring is made using same method.
1.7 statistical method
All data processings are analyzed using SPSS10.0 statistical softwares.Quantitative data represents with mean ± standard deviation,
The t compared using the sample average of Group Design two is examined, and the comparison of the quantitative data of duplicate measurements is using Repeated Measurements
Variance analysis, gender comparison uses chi-square criterion, and comparitive study uses single ordinal contingency data data Wilcoxon rank tests.System
Meter inspection uses two-sided test, with P<0.05 is that difference is statistically significant.
2 results
Clinical score difference is statistically significant between different time points before and after treatment（F=217.20, P=0.000）.2 kinds are not
With between treatment method, difference is also statistically significant（F=5.45, P=0.000）.2 weeks, 1 month after 2 groups of patient's treatments
There is decline before relatively treating, difference is statistically significant（P<0.01）.Point out treatment group compared with control group, there is improvement to face
The effect of bed scoring.The clinical score of knee osteoarthritis after 2 groups of patients treat 1 month compares, and there is lower clinic in treatment group
Score, but difference is not statistically significant（P>0.05）.Pointing out treatment group to be treated with control group improves the effect phase of clinical score
Seemingly, or even a more preferable improvement result is had.
The different time of measuring knee osteoarthritis clinical scores of 32 groups of patients of table (±s)
| Group | Before treatment | 2 weeks after treatment | 1 month after treatment |
| Treatment group | 21.34±3.75 | 13.27±4.93## | 12.13±5.07## |
| Control group | 21.81±2.23 | 14.05±3.75## | 15.71±4.22*## |
Note：Compared with treatment group, * is P<0.05, * * is P<0.01, with being compared before treatment, # is P<0.05, ## is P<0.01.
Clinical score difference is statistically significant between different time points before and after treatment（F=137.98, P=0.000）.2 kinds
Between different treatment methods, difference is also statistically significant（F=13.11, P=0.000）.2 weeks, 1 after 2 groups of patient's treatments
There is decline the moon before relatively treating, and difference is statistically significant（P<0.01）.Point out treatment group compared with control group, there is reduction
The effect of arthralgia.The VAS scorings that 2 groups of patients treat 1 month are compared, and there is lower clinical score in treatment group, but difference does not have
It is statistically significant（P>0.05）.Point out treatment group similar to the effect that control group treats improvement clinical score.
VAS scorings are compared before and after 42 groups of case treatments of table（±s）
| Group | Before treatment | 2 weeks after treatment | 1 month after treatment |
| Treatment group | 73.17±11.03 | 43.56±12.98## | 23.14±11.08## |
| Control group | 71.44±13.74 | 47.17±13.52## | 24.77±12.19## |
Note：Compared with treatment group, * is P<0.05, * * is P<0.01, with being compared before treatment, # is P<0.05, ## is P<0.01.
The cervical spondylopathy of model case medical record one
Chen, female, 50 years old, cervical syndrome and with hyperosteogeny, difficulty of walking.Many places are gone to a doctor, DeGrain.Use this
After 5 courses for the treatment of of plaster treatment of invention, pain symptom disappears, and can normally walk and be engaged in light physical labor.Pay a return visit within 1 year, without multiple
Hair.
The osteoproliferation of medical record two
Mr. Wang, male, 50 years old, suffers from hyperosteogeny, bends over throughout the year, difficulty in walking.After 6 courses for the treatment of of plaster treatment using the present invention,
Can freedom of movement.
The scapulohumeral periarthritis of medical record three
Lee, female 38 years old, suffers from scapulohumeral periarthritis, shoulder pain 1 year is aggravated when tired, act, abduction limitation of activity in shoulder joint.Outside
Lose money in a business after 3 courses for the treatment of of invention plaster, symptom progressively mitigates.
The rheumatic arthritis of medical record four
Zhao, female, 56 years old, rheumatic arthritis, double knee joint pain.Treated through antirheumatic, weight when light during symptom is often anti-
It is multiple.After outer patch 6 courses for the treatment of of plaster of the present invention, symptom mitigation continues pain disappearance, function of joint after three courses for the treatment of of medication normal.
Pay a return visit within 1 year, no recurrence.
The rheumatoid arthritis of medical record five
Zhang, female, 62 years old, rheumatoid arthritis, hand, sufficient many places arthralgia, partial joint deformation, difficulty in walking.Outer patch
After 4 courses for the treatment of of plaster of the present invention, symptom mitigation continues pain after 3 courses for the treatment of of medication and disappears, can normally walk.
Claims (6)
1. a kind of external medicine composition for treating osteoarthropathy, it is characterised in that it includes following component：
Radix Angelicae Sinensis, the red sage root, frankincense, myrrh, the root of bidentate achyranthes, levisticum, cassia twig, asarum is windproof, schizonepeta, the Radix Astragali, rhizoma zingiberis, rhizoma cibotii, tag processed,
The coptis, radix scutellariae, rheum officinale, rice vinegar.
2. a kind of external medicine composition for treating osteoarthropathy according to claim 1, it is characterised in that：It include with
The raw material of lower parts by weight：
10-30 parts of Radix Angelicae Sinensis, 15-45 parts of the red sage root, 6-18 parts of frankincense, 6-18 parts of myrrh, 8-28 parts of the root of bidentate achyranthes, 8-28 parts of levisticum, cassia twig
5-25 parts, 3-15 parts of asarum is windproof 6-30 parts, 6-18 parts of schizonepeta, 10-30 parts of the Radix Astragali, 5-25 parts of rhizoma zingiberis, 10-40 parts of rhizoma cibotii, system
6-18 parts of tag, 3-9 parts of the coptis, 3-15 parts of radix scutellariae, 2-8 parts of rheum officinale, rice vinegar is some.
3. a kind of external medicine composition for treating osteoarthropathy according to claim 2, it is characterised in that：It include with
The raw material of lower parts by weight：
15-25 parts of Radix Angelicae Sinensis, 25-35 parts of the red sage root, 10-14 parts of frankincense, 10-14 parts of myrrh, 15-21 parts of the root of bidentate achyranthes, 15-21 parts of levisticum,
10-20 parts of cassia twig, 6-12 parts of asarum is windproof 12-24 parts, 9-15 parts of schizonepeta, 15-25 parts of the Radix Astragali, 10-20 parts of rhizoma zingiberis, rhizoma cibotii 20-
30 parts, tag 9-15 parts processed, 5-7 parts of the coptis, 6-12 parts of radix scutellariae, 4-6 parts of rheum officinale, rice vinegar is some.
4. a kind of external medicine composition for treating osteoarthropathy according to claim 3, it is characterised in that：It include with
The raw material of lower parts by weight：
The windproof 18 portions of chaste trees of 20 parts of Radix Angelicae Sinensis, 30 parts of the red sage root, 12 parts of frankincense, 12 parts of myrrh, 18 parts of the root of bidentate achyranthes, 18 parts of levisticum, 15 parts of cassia twig, 9 portions of asarum
12 parts of mustard, 20 parts of the Radix Astragali, 15 parts of rhizoma zingiberis, 25 parts of rhizoma cibotii, 12 portions of tag, 6 parts of the coptis, 9 parts of radix scutellariae, 5 parts of rheum officinale processed, rice vinegar is some.
5. a kind of preparation method of the Chinese medicine composition for the treatment of osteoarthropathy as described in claim any one of 1-4, its feature
It is：Dry medicine materical crude slice is taken, fine powder is worn into pulverizer, 120 mesh sieves is crossed, is put into container；Rice vinegar is added, dough is tuned into.So
Hospital gauze is cut into 10*10cm square afterwards, by 6g Chinese medicine dough hand rubbings into wad, is put on gauze, lid last layer
Transparent plastic paper, diameter 8cm circular shaped plaster is slowly forced into finger to surrounding.
6. a kind of ointment for treating rheumatism as described in claim any one of 1-4, it is characterised in that by traditional Chinese medicine fine powder and rice vinegar
1：1 weight is than adding rice vinegar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710216722.4A CN107137677A (en) | 2017-04-05 | 2017-04-05 | Warm sun patch |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710216722.4A CN107137677A (en) | 2017-04-05 | 2017-04-05 | Warm sun patch |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107137677A true CN107137677A (en) | 2017-09-08 |
Family
ID=59773503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710216722.4A Pending CN107137677A (en) | 2017-04-05 | 2017-04-05 | Warm sun patch |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107137677A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116509981A (en) * | 2022-01-22 | 2023-08-01 | 范生昭 | A kind of traditional Chinese medicine plaster for treating bruises, bone hyperplasia and bone spurs and its preparation method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770814A (en) * | 2016-04-08 | 2016-07-20 | 段练 | Laurel-attached yang warming plaster |
-
2017
- 2017-04-05 CN CN201710216722.4A patent/CN107137677A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770814A (en) * | 2016-04-08 | 2016-07-20 | 段练 | Laurel-attached yang warming plaster |
Non-Patent Citations (1)
| Title |
|---|
| 蔡友毅等: ""以‘络脉痹阻’论治腰椎间盘突出症265例总结"", 《中医药导报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116509981A (en) * | 2022-01-22 | 2023-08-01 | 范生昭 | A kind of traditional Chinese medicine plaster for treating bruises, bone hyperplasia and bone spurs and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100560119C (en) | An external plaster for promoting blood circulation and removing numbness | |
| CN103565876B (en) | A kind of medicinal moxa roll and uses thereof | |
| CN103933129B (en) | Plaster for treating pain | |
| CN101085222A (en) | Plaster for relieving pain | |
| CN102389561B (en) | Externally applied hot washing traditional Chinese medicinal composition for blood circulation invigorating and pain relieving and application thereof | |
| CN106039271A (en) | Plaster for treating knee osteoarthritis | |
| CN107137677A (en) | Warm sun patch | |
| CN103142707B (en) | Traditional Chinese medicine paste or treating chronic soft tissue injury and preparation method thereof | |
| CN114588242B (en) | Pharmaceutical composition for treating rheumatoid arthritis | |
| CN105664041A (en) | Traditional Chinese medicinal composition for dispelling cold and removing dampness | |
| CN104491828B (en) | A kind of temperature leads to Traditional Chinese medicine used as analgesic preparation and its paste preparation method | |
| CN104162114B (en) | Traditional Chinese medicine composition for treating wind-cold obstruction type cervical spondylotic radiculopathy | |
| CN100493544C (en) | A kind of external medicine for treating rheumatism | |
| CN102552593B (en) | Chinese medicinal composition for treating wind-cold-dampness arthralgia and using method thereof | |
| CN105412206A (en) | Traditional Chinese medicine preparation with relaxing tendon and dissipating hard mass effects | |
| CN1883565A (en) | Gel for treating rheumatic arthritis and traumatic injury and method for preparing same | |
| CN105853902A (en) | Plaster for treating lumbar disc herniation and preparation method thereof | |
| CN102552823A (en) | Medicine for treating osteoarthritis and preparation method thereof | |
| CN102755487A (en) | Traditional Chinese medicine powder for eliminating dampness and invigorating blood circulation | |
| CN114272284B (en) | A traditional Chinese medicine composition, preparation and application for treating blood stagnation type osteoarthritis | |
| CN102178816A (en) | Traditional Chinese medicine composition for treating pain in neck, waist and lower extremities | |
| CN107080798B (en) | Plaster for dredging collaterals and preparation method thereof | |
| CN105326985A (en) | Traditional Chinese medicinal preparation for treating cold dampness closed resistance-type rheumatoid knee arthritis | |
| CN117180395A (en) | Traditional Chinese medicine compound for treating lumbar disc herniation and axial type spinal arthritis and preparation method and application thereof | |
| CN104524133A (en) | Traditional Chinese medicinal composition for kidney tonifying, exterior strengthening and beauty treating |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170908 |
|
| WD01 | Invention patent application deemed withdrawn after publication |